Mayo Clinic and AliveCor are developing a low-cost, portable screening tool for long QT, which can cause sudden cardiac death.

Simplify Medical raised $21 million in series B funding to support two U.S. pivotal trials of its nonmetal cervical artificial disc.

Voluntis picked up U.S. and EU nods to integrate Sanofi's Toujeo into its basal insulin management app and plans to add more.

Quest Diagnostics has completed its acquisition of a pair of laboratory businesses in Texas, establishing a foothold in the southwestern U.S.

The finding suggests doctors could use biomarkers tied to the visual system to spot the disease early and monitor its advance.

Quidel has penned a deal to acquire Alere’s triage assets as it boosts its position in the point-of-care market.

BGI Genomics has completed its IPO, giving it cash at a time when it is trying to establish itself as a major player in biomedical testing.

The device senses the composition of blood clots to provide doctors with insights into how best to treat blockages.

Philips earned an FDA nod for its wearable device that delivers blue light to the skin to ease the symptoms of mild psoriasis.